Celltrion, Stock Price -0.61% at This Time... 289,989 Shares Net Bought by Individuals in the Last 5 Days

As of 12:30 PM on the 21st, Celltrion is trading at 244,000 KRW, down 0.61% from the previous day. The trading volume is 363,699 shares, which is about 30.39% of the previous day's volume. Celltrion is known as a protein and biopharmaceutical manufacturing company.

On October 19, Lee Dong-geon, a researcher at Shinhan Financial Investment, stated, "After a stock rally due to strong first-half performance, the stock price rise in the second half has slowed. However, 1) excluding R&D expenses for COVID-19 treatments, strong performance is expected to continue, 2) sales growth of the highly profitable Remsima SC in 2021 is anticipated, and 3) considering the bio-similar development capabilities and the existing follow-up pipeline, there is sufficient basis for further stock price increases at this point." He set Celltrion's target price at 360,000 KRW.

Over the past five days, individual investors have net purchased 289,989 shares of Celltrion, while foreigners and institutions have net sold 280,373 shares and 29,052 shares, respectively.

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.